Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanmuga HospitalBOM:544365 +14.03%21 ROE % is 10.45% as of Mar. 2026, which is 71% below its 10-year median of 36.25. GuruFocus rates BOM:544365 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Shanmuga Hospital ranks better than 62.74% on this metric.
The historical rank and industry rank for Shanmuga Hospital's ROE % or its related term are showing as below:
BOM:544365'
s ROE % Range Over the Past 10 Years
Min: 10.19 Med: 36.25 Max: 95.16
Current: 10.19
During the past 5 years, Shanmuga Hospital's highest ROE % was 95.16%. The lowest was 10.19%. And the median was 36.25%.
BOM:544365's ROE % is ranked better than 62.74% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 6.09
vs BOM:544365: 10.19
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Shanmuga Hospital ROE % Related Terms
Shanmuga Hospital ROE % Historical Data
* Premium members only.
The historical data trend for Shanmuga Hospital's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Shanmuga Hospital's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanmuga Hospital ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanmuga Hospital's ROE % distribution charts can be found below:
* The bar in red indicates where Shanmuga Hospital's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Shanmuga Hospital (BOM:544365) has a ROE % of 10.45% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanmuga Hospital and its competitors. This is 71% below median its historical median of 36.25. Over the past decade, Shanmuga Hospital's ROE % has ranged from 10.19 to 95.16. According to the industry distribution chart, Shanmuga Hospital ranks #231 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 37.3%.
Is Shanmuga Hospital's ROE % too high?
Shanmuga Hospital's current ROE % of 10.45% is 71% below median its 10-year median of 36.25. Over the past 10 years, this metric has ranged from a low of 10.19 to a high of 95.16. The Healthcare Providers & Services industry median ROE % is 6.09. Shanmuga Hospital's value of 10.45% is 71.6% above this industry median. Based on the distribution chart, Shanmuga Hospital ranks #231 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanmuga Hospital has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Shanmuga Hospital's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shanmuga Hospital ranks #231 out of 620 companies for ROE %. This puts Shanmuga Hospital in the upper half of its industry. The industry median ROE % is 6.09. Shanmuga Hospital's value of 10.45% is 71.6% above this benchmark. Historically, Shanmuga Hospital's own ROE % has ranged from 10.19 to 95.16 over the past decade. While the company's 10-year median is 36.25 vs. the industry median of 6.09, Shanmuga Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.09, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanmuga Hospital's current ROE % of 10.45% is 71.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanmuga Hospital and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanmuga Hospital's current ROE % is 10.45%, which is 71% below median its own 10-year median of 36.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanmuga Hospital stock overvalued right now?
Shanmuga Hospital (BOM:544365) has a current ROE % of 10.45%. The current ROE % is 10.45%, which is 71% below median its 10-year median of 36.25 and 71.6% above the Healthcare Providers & Services industry median of 6.09. Shanmuga Hospital's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shanmuga Hospital (BOM:544365), the current ROE % is 10.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanmuga Hospital Ltd is a Multispecialty Hospital. It is Equipped with developed healthcare technology and has an approximately 151-bed capacity, it addresses the community's medical needs, serving patients from nearby regions. The hospital is committed to high-quality healthcare services, including prevention, treatment, and rehabilitation. Its medical facility encompasses an Oncology Unit, High Dependency Unit, Emergency Department, Outpatient Consultation Services, Cardiac Care Unit, Intensive Care Unit, Neonatal Intensive Care Unit, Labour Room, Endoscopy Room, Neurosurgery Unit, and Cardiac Unit. The Diagnostic Centre features developed laboratory and imaging technologies such as X-ray, Ultrasound, Computed Tomography scan, Magnetic Resonance Imaging and modular operational theatres.
21GF Score
Get the complete analysis for BOM:544365
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544365 has been successfully added to your 
